Magnesium: A Mineral Essential for Health Yet Generally Underestimated or Even Ignored

Abstract

Magnesium is the fourth most common mineral in the human body after calcium, potassium and sodium. Magnesium must be continuously replenished through foods and water intake because it is not synthesizable. Chronic inadequate intake of magnesium over long period of time can manifest as latent magnesium deficiency with symptoms such as muscle weakness, cramps, fatigue, neurological and cardiovascular dysfunctions, reduced bone mineralization and strength. Reports published by WHO have estimated that ~two thirds of Americans and French have magnesium intake below the recommended amounts but only a small numbers are overtly depleted. The authorities in Finland were concerned of the negative impact of geochemical magnesium deficiency in the eastern region of Finland and its adverse effect on heart health. A program was initiated to increase magnesium intake though supplementation; this has contributed to progressive fall of death rate due to heart-related issues. Restoring and sustaining adequate magnesium store are easy and inexpensive.
Some 40% of total body magnesium is intracellular and ~60% in bone and teeth with less than 1% in circulation. Intracellular magnesium deficiency may or may not be reflected as overt hypomagnesaemia making measurement of plasma/serum magnesium potentially misleading when “normal” plasma/serum concentration is “interpreted” to exclude deficiency.
In this review, the role of magnesium at cellular level, its homeostasis and major clinical conditions associated with magnesium deficiency in adults will be briefly discussed. Assessment of magnesium status and its potential deficiency by examining individual’s “modus vivendi” and/or the use of laboratory tests will be highlighted. Finally, various therapeutic modalities and monitoring of treatment will be summarized.

Full text

Magnesium: A Mineral Essential for Health Yet Generally Underestimated
or Even Ignored
Adel AA Ismail1* and Nour A Ismail2
1Consultant in Clinical Biochemistry and Chemical Endocrinology (RTD), Pinderfiels and Leeds Teaching Hospitals, West Yorkshire, England
2Pinderfiels and Leeds Teaching Hospitals, West Yorkshire, England
*Corresponding author:
Received date: May 13, 2016; Accepted date: June 15, 2016; Published date: June 23, 2016
Copyright: © 2016 Ismail AAA, et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted
use, distribution, and reproduction in any medium, provided the original author and source are credited.
Abstract
Magnesium is the fourth most common mineral in the human body after calcium, potassium and sodium.
Magnesium must be continuously replenished through foods and water intake because it is not synthesizable.
Chronic inadequate intake of magnesium over long period of time can manifest as latent magnesium deficiency with
symptoms such as muscle weakness, cramps, fatigue, neurological and cardiovascular dysfunctions, reduced bone
mineralization and strength. Reports published by WHO have estimated that ~two thirds of Americans and French
have magnesium intake below the recommended amounts but only a small numbers are overtly depleted. The
authorities in Finland were concerned of the negative impact of geochemical magnesium deficiency in the eastern
region of Finland and its adverse effect on heart health. A program was initiated to increase magnesium intake
though supplementation; this has contributed to progressive fall of death rate due to heart-related issues. Restoring
and sustaining adequate magnesium store are easy and inexpensive.
Some 40% of total body magnesium is intracellular and ~60% in bone and teeth with less than 1% in circulation.
Intracellular magnesium deficiency may or may not be reflected as overt hypomagnesaemia making measurement
of plasma/serum magnesium potentially misleading when “normal” plasma/serum concentration is “interpreted” to
exclude deficiency.
In this review, the role of magnesium at cellular level, its homeostasis and major clinical conditions associated
with magnesium deficiency in adults will be briefly discussed. Assessment of magnesium status and its potential
deficiency by examining individual’s “modus vivendi” and/or the use of laboratory tests will be highlighted. Finally,
various therapeutic modalities and monitoring of treatment will be summarized.
Keywords: Magnesium; Mineral; Human health; Food
Background
e relationship between magnesium and health has been
recognized some 400 years ago and well before magnesium was even
identied as an element. e English summer in 1618 was
exceptionally hot and dry. A farmer by the name of Henry Wicker in
Epsom, Surrey dug out few wells in his farm to get water for his herd of
cows. He noticed that his thirsty animals refused to drink this water
because it had a tarty and bitter taste. However he noted that this water
has the ability to rapidly heal scratches, sores and rashes both in
animals and humans. Tried by others, the fame of this water was
spread by the word of mouth. Londoners ocked to Epsom which
became a Spa town, surpassing others more fashionable ones at the
time such as Tunbridge wells in Kent for its water and salt. A physician
(also a Botanist) with extensive practice in London by the name of
Nehemiah Grew noted that the salt in this water had a laxative eect.
is “mind-boggling” discovery was patented as a purging salt and a
factory in London was established for world-wide marketing. In
England this salt was (and still is) known as “Epsom Salt” and in
continental Europe as “Salt Anglicum“.
Late in the 17th century and thereaer, Epsom salt was one of the
most popular medicinal drugs. e people who used it did not know
exactly why it was so benecial, but they did understand that in some
way it was good for health and promoted longevity. Even now, it is
surprising to know that there is an “Epsom Salt Council” in the UK
whose members are wild about the goodness of “Epsom Salt”.
Currently, 13 wonderful ways have been described for the use of
“Epsom Salt” by this council.
Epsom Salt is a magnesium salt (hydrated magnesium sulphate;
MgSO4.7H2O). In 1755, the Scottish Chemist Joseph Black in
Edinburgh identied magnesium as an element and the English
chemist Sir Humphrey Davy was the rst to isolate magnesium by
electrolysis in 1808. e 19th century was the age of chemistry of
magnesium; its biology however became clearer during the 20th
century. e importance of magnesium in health remained overlooked
or even ignored in the 21st century. is may be attributed to (a) the
amorphous ramications of magnesium deciency causing a wide
range of clinical manifestations and (b) the common and overuse of
plasma/serum magnesium measurement when deciency is suspected,
the lack of understanding of the limitations of this test and it’s oen
misinterpretation by health practitioners [1]. It is not therefore
surprising that magnesium deciency is not uncommon in the general
population and even in some people with apparently healthy life style
who may be decient of such important mineral.
Journal of Nutrition & Food Sciences Ismail and Ismail, J Nutr Food Sci 2016, 6:4
http://dx.doi.org/10.4172/2155-9600.1000523
Research Article Open Access
J Nutr Food Sci
ISSN:2155-9600 JNFS, an open access journal Volume 6 • Issue 4 • 1000523
adelaaismail@aol.com
Adel AA Ismail, Consultant in Chemical Endocrinology , Pinderfiels and Leeds T eaching Hospitals, West Y orkshire, England, Tel: 2189456484;
E-mail:

Magnesium, a Major But Under-recognized and
Underestimated Mineral
Of the 90 naturally occurring elements in the planet earth, ~25 are
considered to be essential for health in humans. Four of these 25
namely carbon, oxygen, hydrogen and nitrogen constitute ~97% of
body building blocks. e other 21 elements accounting for ~3% of all
elements in human’s body, of which 8 are “anions” namely
phosphorous, sulphur, chlorine, iodine, uorine, boron, chromium and
silicon; and 13 are metals “cations”. Based on body contents and
recommended daily allowance (RDA), only four metals are regarded as
“majors”; these are calcium, potassium, sodium and magnesium; the
other 9 are required in relatively much smaller amounts and are
designated as “trace-metals”; these are iron, zinc, manganese, copper,
selenium, molybdenum, cobalt, tin and vanadium.
Although calcium, potassium and sodium are readily recognizable
as major minerals, magnesium is neither commonly known nor
perceived as a major one, even by some health professionals despite its
relatively high recommended daily allowance (RDA). For example, the
RDA of magnesium is ~50% and ~25% that recommended for calcium
and sodium respectively and ~26 times greater than that of iron, the
top of all trace metals in terms of RDA. Sustaining magnesium balance
is not only dependent on RDA but its absorption and retention in the
body. Age is an important physiological factor because absorption of
magnesium from the gut is reduced and its loss from the body in urine
increases with age in both genders. Consequently, magnesium
deciency occurs more oen in the elderly than in the young.
Furthermore, the incidence is also likely to vary signicantly from one
area to another because of the large variation in magnesium contents
in drinking water which can provide up to 30% of daily requirement.
Brief Note on the Biological Role of Magnesium at
Cellular Level
e 19th century was the age of chemistry of magnesium; its biology
however became clearer during the 20th century. Approximately 40% of
magnesium is intracellular and some 60% in bone and teeth with 1%
or less is present in the circulation [1].
It may be important to reiterate that although magnesium intake is
in the form of elemental radical, in body uids magnesium do not
function nor operate biologically in this form i.e., “native chemical
radicals” but as “hydrated-ions”, enclosed within shells of water which
confer and exert a profound inuence on their electrochemical,
biochemical and physiological roles.
Magnesium
in vivo
(Mg2+) exhibits a rather unique or even peculiar
characteristic in its ionic hydration form, being distinctly dierent
from the other three major minerals namely Ca2+, K+ and Na+. Such
dierence is important to highlight because it illustrates the physical
uniqueness of hydrated Mg2+ ion and its recognition at molecular level
(Table 1).
Table 1 shows the massive and disproportionate increase in the
Mg2+ atomic radius upon hydration compared with the other three
major ions [2,3]. is is because Mg2+ is a highly “charge dense” ion
compared not only with Na+, K+ or Ca2+, but all other cations, thus
holding the waters’ shell tightly by a factor of 103-104, rigidly within
hexa-coordinated hydration shell. It was suggested that this unique
characteristic makes the hydrated Mg2+ ion more recognisable for
various molecular actions/transport.
Atomic Wt. radius
(Est) Ionic radius, picometer (Est) Increase in
hydrated
Na+ 23 102-116 pm ? X25 fold
K+ 39 138-152 pm ? X4 fold
Ca2+ 40 100-114 pm ? X25 fold
Mg2+ 24 72-86 pm ? X400 fold
Table 1: Changes in atomic radius on hydration (estimated).
Biologically, magnesium is regarded with justication as a “chronic
regulator” and biochemically as a “forgotten electrolyte”. e number
of cells in an adult is ~37 trillion [4] and cellular biochemistry/
physiology is complex. Biological processes carried out within each cell
and between adjacent cells have to be orderly and function
harmoniously and in synchrony using highly complex systems of
neuroendocrine bio-communication. Individual living cell receives a
large number of signals such as stimulation to grow, to divide, to
initiate or stop the making of specic bio-components, to trigger an
immune response et cetera. Each signal needs to be correctly
transmitted, properly read, interpreted and clearly communicated both
within individual cell and between adjacent cells in the rst place.
ese processes are regulated by specic intracellular proteins/
enzymes each dedicated to a specic biological task which may not be
only sequential but require appropriate activation/initiation to start a
process followed by deactivation/stoppage signal to terminate such
task. Mitochondria within individual cell also generate its own energy
utilizing a cascade of proteins/enzymes which drive this process. When
a cell dysfunction, repairing processes is attempted and when fails, the
dysfunctional cell commits orderly and voluntary suicide (i.e.,
apoptosis). Central to all these cellular processes is that each cellular
component must be at the right place and function at the right time,
both within and between cells.
e regulators of all the above examples of cellular functions are
catalysed by some 500 enzymes known biochemically as Kinases which
essentially coordinate, control and integrate such complex web of
orderly processes. Kinases have a vital role in signal transduction and
the production and actions of second messengers such as c-AMP,
diacylglycerol, calmodulin and c-GMP. Kinases activate or inhibit
individual protein/component, route them to a specic cellular
location, or block their interaction with others (i.e., establishing an
orderly production-line). To transmit their orders, kinases label
specic location(s) within a corresponding protein/component with
polar phosphate group (PO3-) i.e., phosphorylation. e source of
polar phosphate group is ATP and Kinases can only bind “Mg-ATP”
complex, allowing it to cleave the γ phosphate group which is
subsequently transferred to the recipient molecule. Phosphorylation is
an ion-radical, electron-spin selective process [5-7] which transforms
(switches on) an inactive molecule into an active or “functional” one
which can then perform a specic biological/biochemical task (or vice
versa). In addition to the phosphorylation of small organic molecules,
up to 30% of functional body proteins are activated by magnesium-
dependent kinases.
Physiologically, magnesium plays an important role in electrolyte
homeostasis being necessary for the activation of ATP/ATPase pumps
such as Na+/K+ pump, Na+/Ca++ , Na+/Mg++ and Mg++/Ca++ pumps
which if decient causes impairment and reduction in their ecacy
and activities. Chronic magnesium deciency with time may
Citation: Ismail AAA, Ismail NA (2016) Magnesium: A Mineral Essential for Health Yet Generally Underestimated or Even Ignored. J Nutr Food
Sci 6: 523. doi:10.4172/2155-9600.1000523
Page 2 of 8
J Nutr Food Sci
ISSN:2155-9600 JNFS, an open access journal Volume 6 • Issue 4 • 1000523

eventually lead to overt pathology and electrolyte disturbances such as
“refractory” hypokalaemia and/or hypocalcaemia. Neither the former
nor the later can be corrected by potassium or calcium treatment alone
and magnesium replacement becomes essential for restitution. It is
therefore paramount to note that magnesium itself is an electrolyte
which plays a major role in the homeostasis of other major electrolytes,
namely Na+, K+ and Ca++. Furthermore, magnesium is necessary for
bone mineral density and strength, protein, carbohydrate and fat
metabolism, energy transfer, storage and use (i.e., bioenergetics, and
oxidative energy metabolism). About 150 magnesium-dependent
kinases are linked to a wide variety of diseases; it is not therefore
surprising that magnesium deciency can potentially cause/exacerbate
a wide range of disorders [8-16].
Magnesium also encourages bone formation [12], directly and
indirectly through its eect on bone hormones such as parathyroid and
vitamin D. Magnesium plays a role in bone mineralization and its
mechanical strength. Several studies have shown a positive relationship
between dietary magnesium intake and bone mineral density (BMD).
ere is evidence to suggest that magnesium supplementation
increases BMD over the course of one year but its impact on bone
fractures is not yet known.
Finally, the underlying reaction mechanism seems to be the same
for all known kinase. Up to 300 dierent kinases are present within a
single cell; each devoted to a particular task, route individual
component to a specic cellular location, or blocks their interaction
with others (i.e., streamlining an orderly production-line). e
dependence of Kinases on magnesium for their function has led to
their nomenclature as “magnesium-dependent kinases”. Magnesium
deciency if present impairs and if depleted impedes kinase’s activity.
Kinases are the largest superfamily of all enzymes in the human body
to which ~one ies of the ~24,000 human genes are dedicated to their
encoding, highlighting their important role in regulating nearly all
intracellular biological processes. e central role of these regulatory
mechanisms in biochemistry/physiology is reected in the worldwide
publication of some 200,000 papers on these subjects over a period of
only 18 months between March 2012 and July 2014.
Magnesium Homeostasis
Considering the many vital roles of magnesium, there was
surprisingly lack of information regarding its homeostasis. Only in the
last decade however two ion channels have been suggested as
magnesium transporters which appear to play a pivotal role in its
homeostasis through the dual processes of its absorption from the gut
and reabsorption by the kidneys. Ion channels conduct a particular ion
aer which it is named while excluding others e.g. Na+, K+ and Ca++
channels. Ion hydration energy (water shell surrounding each ion) and
the charges at the binding sites by the ligand make the internal milieu
within each channel favourable for conducting only a specic ion. e
two dedicated ion channels specically aimed at transporting Mg++
belong to the Transient receptor potential melastatin (TRPM), a sub-
family of the transient receptor potential proteins super-family
involved in transporting other cellular cations such as calcium by
TPRM 3. Recently, TRPM 6 and TRPM 7 have been suggested as
unique transporters for Mg++ termed chanzymes because they possess
a channel and a kinase domain. ese two chanzymes may therefore
represent molecular mechanism aimed at regulating magnesium
homeostasis at cellular level [2,17-22]. ey are dierentially
expressed, with TRPM6 being found primarily in colon and renal
distal tubules. Up-regulation of TRPM 6 occurs in response to
reduction in intracellular magnesium; this in turn enhances
magnesium absorption from the gut and its reabsorption by the
kidneys and can therefore alter whole-body magnesium homeostasis.
TRPM7 is ubiquitous, occurring in numerous organs (e.g. lung). ese
two chanzymes may therefore represent a molecular mechanism
specically aimed at regulating body magnesium balance [2,17-22].
Clinical Conditions Associated with Magnesium
Deciency in Adults
Magnesium deciency is common in the general population as well
as in hospitalized patients and can occur in individuals with an
apparently healthy lifestyle. Latent magnesium deciency is more
common in the elderly, probably exacerbated by oestrogen which
decline in women and men with age. Oestrogen inuence body
magnesium balance through its eect on TRPM6 which may help
explaining the hypermagnesuria in the elderly in general and
postmenopausal in particular. Magnesium deciency is clinically
under-diagnosed condition, yet surprisingly easy to treat [23-27].
We have researched peer reviewed articles on magnesium published
in English between 1990 and April 2011 in MEDLINE and EMBASE
and updated thereaer till April 2015 using database keywords
“magnesium, deciency, diagnosis, treatment and hypomagnesaemia”.
Bibliographies of retrieved articles have been searched and followed.
We have also carried out a manual search of each individual issue of
major clinical and biochemical journals in which most of these reports
have appeared.
Clinically magnesium deciency may present acutely or with
chronic latent manifestations. Clinical presentation of chronic/latent
magnesium deciency may vary from vague and non-specic
symptoms to causing and/or exacerbating the progression of wide
range of diseases such as cardiovascular pathology (CVS), primary
hypertension and diabetes type two.
Magnesium is a physiological calcium antagonist and natural
calcium channel blocker and thereby essential for normal neurological
and muscular function [28,29]. In skeletal and smooth muscle,
magnesium promotes relaxation whilst calcium stimulates contraction.
A high calcium/magnesium ratio caused by magnesium deciency
and/or high calcium intake may aect this nely regulated homeostatic
balance and may be a factor in the increased risk of cardiovascular
events in patients receiving calcium supplementation [30,31].
Magnesium deciency is implicated/present in almost all patients with
hypokalaemia and those with magnesium-dependent hypocalcaemia
[32-38].
A growing body of literature has demonstrated a wide pathological
role for magnesium deciency. In 221 peer reviewed studies published
from 1990 to April 2015, magnesium deciency was associated with
increased risk and prevalence in the eleven conditions listed in Table 2
(irrespective of the nature, design, parameters, size and statistical
approach of these studies). Such an inverse relationship was also
demonstrable irrespective of the wide range of methods used to assess
magnesium body stores.
Similarly, in 79 studies over the same period, magnesium deciency
was found to predict adverse events and a reduced risk of pathology
were noted when supplementation/treatment was instituted. In a
recent study [39] a direct aetiological link between magnesium
deciency, impaired glucose tolerance and CVS was demonstrated. In
this study thirteen postmenopausal American women (12 Caucasian
Citation: Ismail AAA, Ismail NA (2016) Magnesium: A Mineral Essential for Health Yet Generally Underestimated or Even Ignored. J Nutr Food
Sci 6: 523. doi:10.4172/2155-9600.1000523
Page 3 of 8
J Nutr Food Sci
ISSN:2155-9600 JNFS, an open access journal Volume 6 • Issue 4 • 1000523

and 1 African-American) volunteered to reduce their dietary
magnesium intake to ~one third of the recommended daily
requirement (average 101 mg/day). In less than three months, ve
subjects had cardiac rhythm abnormalities and three exhibited atrial
brillation/utter that responded quickly to magnesium
supplementation. Impaired glucose homeostasis was found in 10
volunteers who underwent intravenous glucose tolerance test (IV
GTT). e clinical manifestation was reected in reduced levels in red-
cell membranes; however, serum levels remained within reference
range. is study, though small, is consistent with epidemiological
surveys, supplementation trials and animal studies [40,41] (Table 2 and
[1,11]).
Electrolytes Hypocalcaemia
Hypokalaemia
CVS Ventricular arrhythmias esp. Torsades de Pointes,
Cardiac conduction abnormalities-SVTs,
Abnormal vascular tone, Congestive cardiac failure
Ischaemic heart disease/myocardial infarction
Hypertension Pre-eclampsia/eclampsia, primary hypertension
Endocrine Type II Diabetes Mellitus
Metabolic The Metabolic syndrome
Bone BMD and osteoporosis
Muscular Muscle weakness, fatigue, numbness, tingling, spasms/
cramps/tetany, fibromyalgia
Neurological Irritability, depression, migraines, vertical and horizontal
nystagmus
Cancer Colorectal
Alcoholics Exhibiting any of the above manifestations
Respiratory Asthma
Table 2:
“Modus Vivendi” and Its Role in Identifying Potential
Magnesium Deciency
Potential causes of magnesium deciency are outlined in Table 3. It
may not be dicult to surmise potential magnesium deciency from
an individual’s life-style as body stores are dependent on the balance
between daily intake and renal loss [21,42-44]. Approximately 30-70%
of dietary magnesium intake is absorbed by a healthy gut with negative
magnesium store and high gastric acidity enhancing absorption
[21,28,42-46]. e commonly recommended daily intake for adults is
320-400 mg/day (or 6 mg/kg/body weight for both genders) [47] and
increases during pregnancy, lactation and regular strenuous exercise
[48-50] which increases magnesium losses in urine and sweat. An
average healthy daily diet supplies ~250 mg of magnesium (120 mg per
1000 calories) with green vegetables, cereals, sh and nuts are being a
rich source (Table 4). Rened grains and white our are generally low
in magnesium. Unrened sea salt is very rich in magnesium occurring
at ~12% of sodium mass, however because this makes raw sea-salt
bitter, magnesium (and calcium) are removed making puried table
salt essentially ~99% sodium chloride.
Another important source is water [51,52], with some (but not all)
hard tap water containing more magnesium than so water. Local
water supplier can provide information regarding magnesium
concentration in tap water to each location (e.g. postcode area in the
UK). e bioavailability of magnesium in water is generally good at
~60%; however its absorption from water signicantly decline with age
[53,54].
e magnesium content in tap and/or bottle water varies greatly.
Hardness of water is caused by dissolved calcium and magnesium and
is usually expressed as the equivalent quantity of calcium carbonate in
mg/l (e.g. a hardness of 100 mg/l would contain 40 mg/l of elemental
Ca and/or Mg and 60 mg as carbonate). Water containing >200 mg/l
equivalent calcium carbonate is considered hard; medium hardness is
between 100-200 mg/l; moderately so <100 mg/l and so <50 mg/l
calcium carbonate equivalent. Hardness above 200 mg/l results in scale
deposition on heating if large amount of calcium carbonate is present
because it is less soluble in hot water.
Age; elderly absorb less and lose more magnesium
Daily diet low in magnesium
Soft drinking water, bottle or hard water low in magnesium
Refined salt for cooking and in food
Pregnancy, lactation and regular strenuous exercise
Regular alcohol intake esp. spirits
Malabsorption (also short bowel syndrome/intestinal surgery)
Drugs such as diuretics
Table 3: Factors contributing to chronic magnesium deciency.
Magnesium-rich food contains >100 mg per measure. A measure is a cup of
vegetables, grains, legumes or 2 oz (or 56 g) of nuts and seeds.
Vegetables; Green and leafy e.g. Spinach, seaweed and artichoke
Fish; Halibut (4 oz)
Grains; Barley, Wheat, Oat, Bran, (Whole grain bread)
Legumes; Soybean, Adzuki and black bean
Nuts; Almond, Brazil, Cashews, Pine, Peanuts (Peanut butter)
Seeds; (Dried) Pumpkin, Sunflower, watermelon
Table 4: Magnesium content in food.
It may be important to point out that the ratio of calcium to
magnesium in hard water varies. Hard water may in some cases have
predominantly high concentration of calcium but low in magnesium
or vice versa. Furthermore, the type of anion in the calcium salt is
important. For example, hard water which is rich in calcium carbonate
is usually regarded as “temporary hardness” because on heating,
calcium carbonate precipitates. In other forms of hard waters,
magnesium and/or calcium may combine with anions other than
carbonate, such as sulphate and in this case water is referred to as
“permanently hard” because these elements are not aected by heating.
All naturally occurring magnesium salts unlike those of calcium, are
relatively more soluble in both cold and heated water, including
Citation: Ismail AAA, Ismail NA (2016) Magnesium: A Mineral Essential for Health Yet Generally Underestimated or Even Ignored. J Nutr Food
Sci 6: 523. doi:10.4172/2155-9600.1000523
Page 4 of 8
J Nutr Food Sci
ISSN:2155-9600 JNFS, an open access journal Volume 6 • Issue 4 • 1000523
Conditions associated with magnesium deficiency.

magnesium carbonate. Although hard water is a general term which
encompasses wide ratios of calcium to magnesium, the magnesium
contents in most hard water (but not all) are 5-20 times more than in
so water and can potentially provide up to 30% of daily requirement.
e term so water is straight forward because it is used to describe
types of water that contain few calcium or magnesium ions. So Water
usually comes from peat or igneous rock (volcanic rocks which make
95% of earth’s crust aer the cooling of magma); other sources are
granite and sandstone. All such sedimentary rocks are usually low in
calcium and magnesium. e magnesium content of so drinking
water is between 2-20 mg/l, average ~6 mg/l. e content of
magnesium in bottled water varies from 0-126 mg/litre [55] while
carbonated tonic and soda water contains little or no magnesium. One
gram of instant coee granules releases ~5 mg of magnesium in hot
water; the corresponding gure for tea is ~0.6 mg [56].
Signicant magnesium deciency has been reported in both elderly
self-caring in the community as well as in hospitalized Norwegians
[57]. In a consensus survey involving 37,000 Americans, 39% were
found to ingest less than 70% of the recommended daily magnesium
intake and 10% of women over the age of 70 yrs consume less than
42% of the recommended dietary requirement [58-60]. When dietary
magnesium intake is poor, the kidney can compensate by increasing
fractional reabsorption to >99% of the ltered load, mainly in the loop
of Henle with further reabsorption in the distal tubule. Normally,
plasma magnesium is ltered at the glomeruli apart from the fraction
bound to albumin. Reabsorption of the ltered load can vary
depending on the body store, being lowest when body stores are
adequate to maximum in deciencies. Prolonged periods of poor
dietary intake however would eventually lead to a decline in
intracellular magnesium concentration.
Excessive renal loss is however a common cause of negative
magnesium stores. Alcohol is a known cause, being magnesium
diuretic as even moderate amounts produces magnesiuresis. Alcohol
increases urinary magnesium loss above baseline by an average of
167% (range 90-357%) and its eect is rapid [61-66] and occurs even
in individuals with an already negative magnesium balance. Alcohol
consumption has increased with availability and cheaper cost [65,67]
and in moderate amounts, is considered socially and culturally
acceptable (taken as 2 to 4 units’ i.e., 16-32 g of alcohol a day, though
there is no standard denition). It may be of interest to point out that
spirits such as gin, rum, brandy, cognac, vodka and whisky contain
little or no magnesium; fermented apple ciders have 10-50 mg/l of
magnesium while beer and wine have levels ranging from ~30-250
mg/l. Although drinks such as some ciders, beer and wine may be
considered “magnesium-rich”, they cannot be recommended as a
reliable source. Furthermore, large consumption of magnesium rich
beer and wine can have a laxative or even diarrheatic eect, potentially
impeding bioavailability and absorption.
It appears reasonable therefore to suggest that a life-style associated
with low dietary magnesium intake in food and drinking water,
puried table salt for cooking and in-food, regular and strenuous
exercise coupled with moderate and regular consumption of alcoholic
drinks which cause a net renal magnesium loss can additively lead to
negative balance over time. Magnesium deciency can be further
compounded with malabsorption and those receiving medications
[68-72] such as diuretics (loop and thiazide), proton pump inhibitors,
tacrolimus, chemotherapeutic agents such as cisplatin, ciclosporin,
omeprazole, cetuximab and some phosphate-based drugs.
In summary, modus vivendi when carefully examined can
determine the potential of latent magnesium deciency which may be
associated with a wide range of major pathologies. It is however a
common practice for clinicians to rely more on laboratory tests in the
diagnosis of magnesium deciency.
Laboratory Tests and Assessment of Magnesium
Deciency
Assessment of magnesium status is biochemical. Serum magnesium
is the most commonly requested test and is informative when
magnesium is reduced indicating hypomagnesaemia. However, normal
serum magnesium (commonly reported ~0.75 mmol/l to ~1.2 mmol/l)
remained problematical because in patients suspected with magnesium
deciency serum concentration can be normal despite whole body
deciency [73-76]. is is not surprising because only 1% or less of
body magnesium is in blood; the bulk of magnesium is intracellular
bound to numerous subcellular components and these are the moieties
which account for its biological role. In other words, it is the
intracellular bound magnesium which expresses its primary biological
role and normal serum magnesium (total or ionized) must be
interpreted with caution [76]. Low serum magnesium (with normal
albumin) in a fasting or random sample conrms signicant deciency
warranting supplementation. For this reason, the practicable,
inexpensive and commonly used serum magnesium must be regarded
as potentially awed test, capable of identifying magnesium deciency
in some (range from 2.5 to 15%) but not all patients with deciency
and negative body stores. A fraction of bone magnesium appears to be
on a surface limited pool, present either within the hydration shell or
else on the crystal lattice. Based largely on animal studies, it has been
speculated that this form of bone surface magnesium may represent a
limited buering capacity.
To exclude with condence latent/chronic magnesium deciency in
cases with high index of suspicion albeit normal serum magnesium, a
dynamic study namely magnesium loading test would be appropriate if
renal function is normal. is procedure is probably the best
physiological “gold standard test” within the capability of all routine
hospital laboratories. It involves the administration of elemental
magnesium load (as sulphate or chloride) intravenously followed by
assessment of the amount of elemental magnesium excreted in the
urine in the following 24 hrs [77-81]. A large fraction of the given
magnesium load is retained and a smaller amount of the given dose
appears in the urine in patients with latent magnesium deciency.
Such a procedure in the experience of one of us was valuable, accurate
and informative, however, it is time consuming and (understandably)
not commonly used in clinical practice. It is also contra-indicated in
individuals with renal impairment.
Magnesium Loading Test
e loading test measures the body’s retention of magnesium and
therefore reects the degree of deciency [77-81]. Attention to details
is however paramount for valid interpretation of data. Patient should
empty their bladder immediately before the test. e test involves
intravenous administration of 30 mmol of elemental magnesium (1
mmol=24 mg) in 500 ml 5% dextrose over a period of 8-12 hours. A
slow rate infusion is important because plasma magnesium
concentration aects the renal reabsorption threshold and abrupt
elevation of plasma concentration above the normal range would
reduce magnesium retention and increases urinary excretion with its
Citation: Ismail AAA, Ismail NA (2016) Magnesium: A Mineral Essential for Health Yet Generally Underestimated or Even Ignored. J Nutr Food
Sci 6: 523. doi:10.4172/2155-9600.1000523
Page 5 of 8
J Nutr Food Sci
ISSN:2155-9600 JNFS, an open access journal Volume 6 • Issue 4 • 1000523

potential misinterpretation. Urine collection begins with the onset of
magnesium infusion and continues over the next 24 hrs period,
including a last void at end of this period.
Patients with adequate body magnesium stores retain less than 10%
of the infused elemental magnesium load. Latent magnesium
deciency is considered present if less than 25 mmol of elemental
magnesium are excreted in the 24 hrs collection. Repeat of magnesium
loading test to check repletion can also be informative because average
dierence between two repeats is ~2%. Magnesium body stores are
considered repleted when >90% of the elemental magnesium load is
excreted in the following 24 hrs urine.
Magnesium loading test is contraindicated in patients with renal
impediment, salt losing nephropathy, respiratory failure and
medications which aect renal tubular function such as diuretics,
cisplatin, ciclosporin, etc.
A number of studies attempted to simplify the magnesium loading
test [82] by reducing the infused magnesium load to 0.1 mmol of
elemental magnesium per kilogram body weight, reducing the infusion
time to 1-2 hrs and collecting urine over shorter period of 12 hrs. Oral
magnesium loading test was also described. However, although these
modications are simpler, their usage was limited and the 8-12 hour
infusion of 30 mmol remained the standard test.
24-h Urinary Magnesium Excretion
Patients with magnesium deciency, not on medications/alcoholic
beverages and normal renal function, excrete small amounts of
magnesium per day (usually <0.5 mmol or 12 mg). Considerable care
and attention to completeness of 24-h urine collection is necessary
[83].
Treatment Modalities in Patients with Magnesium
Deciency
Magnesium has low-toxicity in people with normal renal function.
Deciency however may not be corrected through nutritional
supplementation only. e most common therapeutic modalities are
intravenous infusion in patients with depletion manifesting as
signicant hypomagnesaemia; and orally (occasionally subcutaneously
[84]) for individuals requiring long-term supplementation. Aerosolized
magnesium sulphate was also used in patients with acute asthma
[85,86].
Intravenous magnesium (up to ~30 mmol of elemental magnesium;
1 mmol=24 mg) is given over a period of hours. A slow rate infusion is
important because plasma magnesium concentration aects the renal
reabsorption threshold and abrupt elevation of plasma concentration
above the normal range can reduce magnesium retention. Magnesium
body stores are considered repleted when >90% of the elemental
magnesium load is excreted in the following 24 hrs urine (see
magnesium loading test). On the other hand, persistent elevation in
serum magnesium in samples taken longer than 24 hrs aer treatment
would be indicative of over-treatment. Other analytes which may be
associated with magnesium deciency are calcium, potassium,
phosphate and vitamin D [87].
Common oral magnesium supplement exists in two forms-chelated
and non-chelated. In the chelated forms, magnesium is attached to
organic radicals; in the non-chelated forms magnesium is in the form
of sulphate, chloride or oxide. Magnesium attached to organic/
aminoacid radicals appears to be better tolerated with superior
bioavailability [88,89] than the commonly available magnesium oxide.
Generally over-treatment leading to signicant hypermagnesaemia is
unlikely to occur in patients on the recommended oral magnesium
supplement. is is because when the intake exceeds daily
requirement, absorption of magnesium from the gut is reduced and its
excretion can exceed 100% of the ltered load caused by active renal
secretion in the urine.
It may be of interest to point out that net magnesium absorption
rises with increasing intake, however fractional absorption falls as
magnesium intake increases (e.g. from 65% at 40 mg intake to 11% at
960 mg). Magnesium absorption from the gut is slow with ~80% of
oral magnesium being absorbed within 6-7 hrs [90]. Note also that
calcium and magnesium competes for absorption, thus too much
calcium in diet/medication can impede magnesium absorption. A ratio
for calcium to magnesium of ~2:1 would allow adequate absorption of
magnesium. However, high oral calcium intake or consumption of
large amounts of calcium-rich products such as dairy foods which have
a ratio of calcium to magnesium of ~10:1 can suciently alter the
balance, potentially reducing magnesium absorption. Dosage regimen
of oral magnesium should therefore take into account the degree of
patients’ magnesium deciency in the rst place, the basic chemical
composition of oral magnesium supplement and its bioavailability plus
other concurrent medications which can increase magnesium loss (e.g.
diuretics, regular intake of spirits) and/or impede its absorption e.g. GI
disorders. Sustained oral magnesium supplementation may be
considered in individuals with life style below RDA intake.
Claims that Epsom salt can be absorbed through the skin are wide
spread throughout the internet with numerous products which can be
added to bath water, in oil, gel or lotions to be directly messaged to
skin for “extra-relaxation, detoxication and exfoliation”. However, no
peer reviewed systematic or controlled studies could be found on this
subject. In a widely quoted but rather limited, not peer-reviewed study
involving 19 subjects (Waring R; School of Bioscience, Birmingham
University, UK) who for one week bathed in water containing 1%
Epsom salt at temperature of ~50°C for ~15 mins, 16 have increased
their baseline serum magnesium concentration before the test by up to
40% and doubled their magnesium content in urine. However, in view
of the dearth of scientically peer-reviewed studies, transdermal
absorption of magnesium should remain speculative.
Conclusion and Take-home Message
Magnesium deciency is an underestimated multifactorial disorder,
common particularly in the elderly. Magnesium deciency can be
associated with consequential morbidity and mortality especially in
patients with other co-morbidities. Serum magnesium is a useful test
because low serum concentration indicates signicant deciency
warranting replacement. However, normal magnesium concentration
must not be used to exclude negative body stores. Modus vivendi has
an important role in identifying at risk patients, such as adults living in
areas with so drinking water or hard water with low magnesium
contents plus other factors listed in Table 2, notably diet and diuretics.
e most informative laboratory investigation is magnesium loading
test.
Magnesium deciency should always be considered in cases such as
electrolyte disturbances (hypocalcaemia and/or hypokalaemia),
arrhythmia, regular/excessive alcohol intake and muscular spasms/
cramps in both normocalcaemic and hypocalcaemic patients. In other
Citation: Ismail AAA, Ismail NA (2016) Magnesium: A Mineral Essential for Health Yet Generally Underestimated or Even Ignored. J Nutr Food
Sci 6: 523. doi:10.4172/2155-9600.1000523
Page 6 of 8
J Nutr Food Sci
ISSN:2155-9600 JNFS, an open access journal Volume 6 • Issue 4 • 1000523

conditions however, it is important that patients at risk in each
category are also identied. e limitations of serum magnesium,
though well known among laboratorians is not widely disseminated
nor emphasized to clinical practitioners. e perception that “normal”
serum magnesium excludes deciency has therefore contributed to the
under-diagnosis of latent/chronic magnesium deciency. Based on
literature in the last two decades, magnesium deciency remained
common and undervalued, warranting a proactive approach because
restoration of magnesium stores is simple, tolerable, and inexpensive
and can be clinically benecial.
References
1. Ismail Y, Ismail AA, Ismail AAA (2010) e underestimated problem of
using serum magnesium measurements to exclude magnesium deciency
in adults; a health warning is needed for “normal” results. Clin Chem Lab
Med 48: 323-327.
2. Moomaw AS, Maguire ME (2008) e unique nature of mg2+ channels.
Physiology (Bethesda) 23: 275-285.
3. Maguire ME, Cowan JA (2002) Magnesium chemistry and biochemistry.
Biometals 15: 203-210.
4. Bianconi E, Piovesan A, Facchin F, Beraudi A, Casadei R, et al. (2013) An
estimation of the number of cells in the human body. Ann Hum Biol 40:
463-471.
5. Buchachenko A, Kouznetsov DA, Orlova MA, Markarian AA (2005)
Magnetic isotope eect of magnesium in phosphoglycerate kinase
phosphorylation. Prc Nat Acad Sci 102: 10793-10796.
6. Grubbs RD, Maguire ME (1987) Magnesium as a regulatory cation:
criteria and evaluation. Magnesium 6: 113-127.
7. Laires MJ, Monteiro CP, Bicho M (2004) Role of cellular magnesium in
health and human disease. Front Biosci 9: 262-276.
8. Alexander RT, Hoenderop JG, Bindels RJ (2008) Molecular determinants
of magnesium homeostasis: insights from human disease. J Am Soc
Nephrol 19: 1451-1458.
9. Rude RK (1998) Magnesium deciency: a cause of heterogeneous disease
in humans. J Bone Miner Res 13: 749-758.
10. Altura BM, Altura BT (1992) Cardiovascular risk factors and magnesium:
relationships to atherosclerosis, ischemic heart disease and hypertension.
Magnes Trace Elem 10: 182-192.
11. Al-Delaimy WK, Rimm EB, Willett WC, Stampfer MJ, Hu FB (2004)
Magnesium intake and risk of coronary heart disease among men. J Am
Coll Nutr 23: 63-70.
12. Touyz RM (2008) Transient receptor potential melastatin 6 and 7
channels magnesium transport and vascular biology: implications in
hypertension. Am J Physiol Heart Circ Physiol 294: 1103-1118.
13. Larsson SC, Bergkvist L, Wolk A (2005) Magnesium intake in relation to
risk of colorectal cancer in women. JAMA 293: 86-89.
14. Ismail AAA, Ismail AA, Ismail Y (2013) Clinical assessment of
magnesium status in the adult; an overview. In magnesium in health and
disease. In: Watson RR, Preedy V, Zibadi S (Eds.), Publisher Humana
Press; Springer Science, USA.
15. Ismail AA, urston A (2010) How magnesium deciency aects bone
health. Osteoporosis Rev 8: 9-12.
16. Swaminathan R (2003) Magnesium metabolism and its disorders. Clin
Biochem Rev 24: 47-66.
17. Murphy E (2000) Mysteries of magnesium homeostasis. Circ Res 86:
245-248.
18. Abed E, Moreau R (2007) Importance of melastatin-like transient
receptor potential 7 and cations (magnesium, calcium) in human
osteoblast-like cell proliferation. Cell Prolif 40: 849-865.
19. Kim BJ, Lim HH, Yang DK, Jun JY, Chang IY, et al. (2005) Melastatin-
type transient receptor potential channel 7 is required for intestinal
pacemaking activity. Gastroenterology 129: 1504-1517.
20. Wolf FI (2004) TRPM7: channeling the future of cellular magnesium
homeostasis? Sci STKE 2004: pe23.
21. Bindels RJ (2010) 2009 Homer W. Smith Award: Minerals in motion:
from new ion transporters to new concepts. J Am Soc Nephrol 21:
1263-1269.
22. Glaudemans B, Knoers NV, Hoenderop JG, Bindels RJ (2010) New
molecular players facilitating Mg(2+) reabsorption in the distal
convoluted tubule. Kidney Int 77: 17-22.
23. Killilea DW, Maier JA (2008) A connection between magnesium
deciency and aging: new insights from cellular studies. Magnesium
Research 21: 77-82.
24. Barbagallo M, Belvedere M, Dominguez LJ (2009) Magnesium
homeostasis and aging. Magnes Res 22: 235-246.
25. Musso CG (2009) Magnesium metabolism in health and disease. Int Urol
Nephrol 41: 357-362.
26. Arinzon Z, Peisakh A, Schrire S, Berner YN (2010) Prevalence of
hypomagnesemia (HM) in a geriatric long-term care (LTC) setting. Arch
Gerontol Geriatr 51: 36-40.
27. Barbagallo M, Dominguez LJ (2010) Magnesium and aging. Curr Pharm
Des 16: 832-839.
28. Saris NE, Mervaala E, Karppanen H, Khawaja JA, Lewenstam A (2000)
Magnesium. An update on physiological, clinical and analytical aspects.
Clin Chim Acta 294: 1-26.
29. Topf JM, Murray PT (2003) Hypomagnesemia and hypermagnesemia.
Rev Endocr Metab Disord 4: 195-206.
30. Bolland MJ, Barber PA, Doughty RN, Mason B, Horne A, et al. (2008)
Vascular events in healthy older women receiving calcium
supplementation: randomsied controlled trial. BMJ 336: 262-266
31. Rowe WJ (2006) Calcium-magnesium-ratio intake and cardiovascular
risk. Am J Cardiol 98: 140.
32. Hermans C, Lefebvre CH, Devogelaer JP, Lambert M (1996)
Hypocalcaemia and chronic alcohol intoxication: Transient
hypoparathyroidism secondary to magnesium deciency. Clin
Rheumatol 15: 193-196.
33. Loughrey CM (2002) Serum magnesium must also be known in profound
hypokalaemia. BMJ 324: 1039-1040.
34. Whang R, Flink EB, Dyckner T, Wester PO, Aikawa JK, et al. (1985)
Magnesium depletion as a cause of refractory potassium repletion. Arch
Intern Med 145: 1686-1689.
35. Whang R, Whang DD, Ryan MP (1992) Refractory potassium repletion.
A consequence of magnesium deciency. Arch Intern Med 152: 40-45.
36. Jones BJ, Twomey PJ (2009) Comparison of reective and reex testing
for hypomagnesaemia in severe hypokalaemia. J Clin Pathol 62: 816-819.
37. Srivastava R, Bartlett WA, Kennedy IM, Hiney A, Fletcher C, et al. (2010)
Reex and reective testing: eciency and eectiveness of adding on
laboratory tests. Ann Clin Biochem 47: 223-227.
38. Ismail AA (2010) On the eciency and eectiveness of added-on serum
magnesium in patients with hypokalaemia and hypocalcaemia. Ann Clin
Biochem 47: 492-493.
39.
magnesium deciency induces heart rhythm changes, impairs glucose
tolerance and decrease serum cholesterol in post-menopausal women. J
Am Coll Nutr 26: 121-132.
40. Fung TT, Manson JE, Solomon CG, Liu S, Willett WC, et al. (2003) e
association between magnesium intake and fasting insulin concentration
in healthy middle-aged women. J Am Coll Nutr 22: 533-538.
41. Rumawas ME, McKeown NM, Rogers G, Meigs JB, Wilson PW, et al.
(2006) Magnesium intake is related to improved insulin homeostasis in
the framingham ospring cohort. J Am Coll Nutr 25: 486-492.
42. Ladefoged K, Hessov I, Jarnum S (1996) Nutrition in short-bowel
syndrome. Scand J Gastroenterol 216: 122-131.
43. Rude RK (1993) Magnesium metabolism and deciency. Endocrinol
Metab Clin North Am 22: 377-395.
44. Quamme GA (2008) Recent developments in intestinal magnesium
absorption. Curr Opin Gastroenterol 24: 230-235.
Citation: Ismail AAA, Ismail NA (2016) Magnesium: A Mineral Essential for Health Yet Generally Underestimated or Even Ignored. J Nutr Food
Sci 6: 523. doi:10.4172/2155-9600.1000523
Page 7 of 8
J Nutr Food Sci
ISSN:2155-9600 JNFS, an open access journal Volume 6 • Issue 4 • 1000523
Nielsen FH, Milne DB, Klevay LM, Gallagher S, Johnson L (2007) Dietary

45. Ford ES, Mokdad AH (2003) Dietary magnesium intake in a national
sample of US adults. J Nutr 133: 2879-2882.
46. Bialostosky K, Wright JD, Kennedy-Stephenson J, McDowell M, Johnson
CL (2002) Dietary intake of macronutrients, micronutrients and other
dietary constituents: United States 1988-94. Vital Heath Stat 11 ed:
National Center for Health Statistics.
47. Rayssiguier Y, Durlach J, Boirie Y (2000) Apports Nutritionnels Conseille
´s pour la population francaise. A Martin coordonnateur, Paris: TEC
DOC Lavoisier.
48. Bohl CH, Volpe SL (2002) Magnesium and exercise. Crit Rev Food Sci
Nutr 42: 533-563.
49. Nielsen FH, Lukaski HC (2006) Update on the relationship between
magnesium and exercise. Magnes Res 19: 180-189.
50. Laires MJ, Monteiro C (2008) Exercise, magnesium and immune
function. Magnes Res 21: 92-96.
51. Rubenowitz E, Axelsson G, Rylander R (1998) Magnesium in drinking
water and body magnesium status measured using an oral loading test.
Scand J Clin Lab Invest 58: 423-428.
52. Monarca S, Donato F, Zerbini I, Calderon RL, Craun GF (2006) Review of
epidemiological studies on drinking water hardness and cardiovascular
diseases. Eur J Cardiovasc Prev Rehabil 13: 495-506.
53. Verhas M, de la Guéronnière V, Grognet JM, Paternot J, Hermanne A, et
al. (2002) Magnesium bioavailability from mineral water. A study in adult
men. Eur J Clin Nutr 56: 442-447.
54. Durlach J, Durlach V, Bac P, Rayssiguier Y, Bara M, et al. (1993)
Magnesium and ageing. II. Clinical data: aetiological mechanism and
pathophysiological consequences of magnesium decit in the elderly.
Magnesium Res 6: 379-394.
55. Garzon P, Eisenberg MJ (1998) Variation in the mineral content of
commercially available bottled waters: implications for health and
disease. Am J Med 105: 125-130.
56. Gillies ME, Birkbeck JA (1983) Tea and coee as sources of some
minerals in the New Zealand diet. Am J Clin Nutr 38: 936-942.
57. Gullestad L, Nes M, Rønneberg R, Midtvedt K, Falch D, et al. (1994)
Magnesium status in healthy free-living elderly Norwegians. J Am Coll
Nutr 13: 45-50.
58. Marier JR (1986) Magnesium content of the food supply in the modern-
day world. Magnesium 5: 1-8.
59. Costello RB, Moser-Veillon PB (1992) A review of magnesium intake in
the elderly. A cause for concern? Magnesium Research 5: 61-67.
60. Byrd RP Jr, Roy TM (2003) Magnesium: its proven and potential clinical
signicance. South Med J 96: 104.
61. Martin He, Mccuskey C Jr, Tupikova N (1959) Electrolyte disturbance in
acute alcoholism: with particular reference to magnesium. Am J Clin
Nutr 7: 191-196.
62. Rylander R, Mégevand Y, Lasserre B, Amstutz W, Granbom S (2001)
Moderate alcohol consumption and urinary excretion of magnesium and
calcium. Scand J Clin Lab Invest 61: 401-405.
63. Rivlin RS (1994) Magnesium deciency and alcohol intake: mechanisms,
clinical signicance and possible relation to cancer development (a
review). J Am Coll Nutr 13: 416-423.
64. kalbeisch Jm, Lindeman Rd, Ginn He, Smith Wo (1963) Eects of
ethanol administration on urinary excretion of magnesium and other
electrolytes in alcoholic and normal subjects. J Clin Invest 42: 1471-1475.
65. Peele S (1997) Utilizing culture and behaviour in epidemiological models
of alcohol consumption and consequences for Western nations. Alcohol
Alcohol 32: 51-64.
66. Poikolainen K, Alho H (2008) Magnesium treatment in alcoholics: a
randomized clinical trial. Subst Abuse Treat Prev Policy 3: 1.
67. Sheron N (2007) Alcohol in Europe: the EU alcohol forum. Clin Med
(Lond) 7: 323-324.
68. Cundy T, Mackay J (2011) Proton pump inhibitors and severe
hypomagnesaemia. Curr Opin Gastroenterol 27: 180-185.
69. Cao Y, Liao C, Tan A, Liu L, Gao F (2010) Meta-analysis of incidence and
risk of Hypomagnesemia with Cetuximab for advanced cancer.
Chemotherapy 56: 459-465.
70. Joo Suk O (2008) Paradoxical hypomagnesemia caused by excessive
ingestion of magnesium hydroxide. Am J Emerg Med 26: 837.
71. Cundy T, Dissanayake A (2008) Severe hypomagnesaemia in long-term
users of proton-pump inhibitors. Clin Endocrinol (Oxf) 69: 338-341.
72. Shabajee N, Lamb EJ, Sturgess I, Sumathipala RW (2008) Omeprazole
and refractory hypomagnesaemia. BMJ 337: a425.
73. Liebscher DH, Liebscher DE (2004) About the misdiagnosis of
magnesium deciency. J Am Coll Nutr 23: 730S-1S.
74. Franz KB (2004) A functional biological marker is needed for diagnosing
magnesium deciency. J Am Coll Nutr 23: 738S-41S.
75. Arnaud MJ1 (2008) Update on the assessment of magnesium status. Br J
Nutr 99: S24-S36.
76. Ismail AAA, Ismail Y, Ismail AA (2015) Deceptive potassium and
magnesium measurements. Diagnosis 1: 272-282.
77. Ismail AAA (1983) In Biochemical Investigation in Endocrinology. Publ:
Acad Press.
78. Rasmussen HS, Nair P, Goransson L, Balslov S, Larsen OG, et al. (1988)
Magnesium deciency in patients with ischaemic heart disease with and
without acute myocardial infarction uncovered by an intravenous loading
test. Arch Int Med 148: 329-332.
79. Goto K, Yasue H, Okumura K, Matsuyama K, Kugiyama K, et al. (1990)
Magnesium deciency detected by intravenous loading test in variant
angina pectoris. Am J Cardiol 65: 709-712.
80. Gullestad L, Midtvedt K, Dolva LO, Norseth J, Kjekshus J (1994) e
magnesium loading test: reference values in healthy subjects. Scand J Clin
Lab Invest 54: 23-31.
81. Gullestad L, Dolva LO, Waage A, Falch D, Fagerthun H, et al. (1992)
Magnesium deciency diagnosed by an intravenous loading test. Scand J
Clin Lab Invest 52: 245-253.
82. Seyfert T, Dick K, Renner F, Rob PM (1998) Simplication of the
magnesium loading test for use in outpatients. Trace metals and
Electrolytes 15: 120-126.
83. Ayuk J, Gittoes NJ (2014) Contemporary view of the clinical relevance of
magnesium homeostasis. Ann Clin Biochem 51: 179-188.
84. Martinez-Riquelme A, Rawlings J, Morley S, Kindall J, Hosking D, et al.
(2005) Self-administered subcutaneous uid infusion at home in the
management of uid depletion and hypomagnesaemia in gastro-
intestinal disease. Clin Nutr 24: 158-163.
85. Blitz M, Blitz S, Hughes R, Diner B, Beasley R, et al. (2005) Aerosolized
magnesium sulfate for acute asthma: a systematic review. Chest 128:
337-344.
86. Villeneuve EJ, Zed PJ (2006) Nebulized magnesium sulfate in the
management of acute exacerbations of asthma. Ann Pharmacother 40:
1118-1124.
87. Bringhurst FR, Demay MB, Krane SM, Kronenberg HM (2008) Bone and
mineral metabolism in health and disease. In Harrison’s principles of
internal medicine. (17th edn.). In: Fauci AS, Braunwald E, Kasper DL,
Hauser SL, Longo DL, Jameson JL, Loscalzo J (eds.), Publ McGraw Hill
Medical.
88. Firoz M, Graber M (2001) Bioavailability of US commercial magnesium
preparations. Magnes Res 14: 257-262.
89. Walker AF, Marakis G, Christie-byng M (2003) Magnesium citrate found
more bioavailability than other magnesium preparations in a randomized
double blind study. Mag Res 16: 183-191.
90. Graham LA, Caesar JJ, Burgen AS (1960) Gastrointestinal absorption and
excretion of Mg 28 in man. Metabolism 9: 646-659.
Citation: Ismail AAA, Ismail NA (2016) Magnesium: A Mineral Essential for Health Yet Generally Underestimated or Even Ignored. J Nutr Food
Sci 6: 523. doi:10.4172/2155-9600.1000523
Page 8 of 8
J Nutr Food Sci
ISSN:2155-9600 JNFS, an open access journal Volume 6 • Issue 4 • 1000523